Each adverse factor scores 1 point.

Total IPI = sum of adverse factors (0–5).

R-IPI redistributes IPI totals into three prognostic groups for patients treated with rituximab-containing anthracycline-based regimens.

International Prognostic Index for Diffuse Large B-cell Lymphoma (IPI and R-IPI)